SAUDI ARABIA DIABETES CARE DEVICES MARKET

Saudi Arabia diabetes care devices market is estimated to grow with a rapid CAGR in the forecast years driven by increasing diabetes cases in the country along with strategic government programs.

Major Market Drivers and Emerging Trends

A significant market driver for the rise in diabetes prevalence in KSA is due to shift toward urbanization and more sedentary lifestyles. Diabetes poses a substantial health challenge in the country with the IDF reported that more than four million individuals had the disease in 2021 and this figure is expected to reach 7.53 million in the next twenty four years. The increase in cases is driven by factors such as an aging demographic and unhealthy lifestyle habits which boost the demand for care devices like insulin pumps.

With new advancements like continuous glucose monitoring and smartphone connectivity, these devices are evolving to offer more advanced solutions. As individuals turn to more advanced equipment for managing their condition, innovations in technology are set to accelerate Saudi Arabia diabetes care devices market size growth.

These devices are essential in diabetes care as they offer streamlined solutions for tracking blood glucose and optimizing treatment effectiveness for healthcare professionals along with patients. The effectiveness of these devices largely depends on their capability to deliver accurate and timely glucose level data while advancements in technology are expected to further fuel market growth. Continuous glucose monitoring systems have revolutionized diabetes management by delivering instant glucose data continuously and removing the requirement for regular fingerstick checks.

This development is also apparent in the advent of innovative products including smart insulin and refined insulin delivery technologies. These advancements enhance the precision and success of diabetes management while also offering improved convenience and simplicity in use. Major market trends are further driven by recent innovations including mobile-app integrated devices and wearable health monitors. As patient self-care gains traction and peripheral diagnostics advance, the need for these devices in the country continues to rise.

The other factor supporting market growth is the strategic government programs in place. Through education initiatives and more funding for healthcare centers, the government has fostered greater understanding of diabetes prevention and management. The diabetes awareness programs along with the emphasis on early intervention and lifestyle modifications by the government are expected to support market growth. Under its Vision 2030 plan the government intends to improve healthcare infrastructure and shift healthcare insurance and services to the private sector. It also plans to set up 21 medical centers network across the country and enhance e-health services with an investment exceeding USD 65 billion.

Regulations concerning diabetes devices in Saudi Arabia are set and implemented by the SFDA. These rules are established to maintain the safety and quality standards of the devices nationwide. The SFDA stipulates that devices including insulin pumps and blood glucose meters must be fully assessed and registered prior to being introduced or distributed in the country.

While diabetes devices offer significant benefits yet the high costs may make them unaffordable for some patients in Saudi Arabia. The high cost may prevent many diabetics from accessing them which could limit the overall market growth. However the market is becoming more competitive as new companies enter and established brands broaden their products. This could make it challenging for manufacturing companies to stand out and gain a significant market share.

Type Insights: Insulin delivery devices segment registered the largest market share

The insulin delivery devices segment captured the largest share as these devices provide significant improvements over conventional insulin administration. It offers patients more flexibility and ease in managing their condition. Devices like insulin pens and pumps streamline the administration of insulin injections which eases the process for patients. These devices streamline the insulin dosing process which eliminates manual measurement and drawing. It therefore reduces the chance of errors and boosts treatment precision.

Blood glucose monitoring devices are also experiencing rapid growth mainly due to the increasing diabetes rates and the rising need for efficient glucose management tools. As lifestyle changes and an aging demographic contribute to the growing diabetes prevalence the demand for dependable BGM devices continues to rise. Innovations in technology have resulted in the more precise and convenient BGM devices which are becoming increasingly popular with patients and healthcare providers.

End-User Insights: Hospitals segment dominated the largest revenue share

The demand for this segment is being amplified by the rising hospital admission rates for diabetes patients who are three times more likely to be hospitalized than those without the condition. Recent advancements in technology have primarily focused on improving care in clinics and hospitals which leads to greater utilization of diabetes devices in these healthcare environments.

The majority of demand comes from the Central provinces and the demand from Eastern and Western regions trailing behind. As the most urbanized area in Saudi Arabia, the Central Province records the highest number of diabetes patients. Meanwhile the Eastern province not only hosts the biggest oil industry in the country but is also a key hub for the population.

Top Market Players

Various major companies in the country are Abbott, Medtronic, Bayer AG, Lifescan, among others. Leading companies in the industry are dedicated to improving their products as a strategy to attract more customers and achieve a larger market share. The approach includes improving product offerings and pursuing acquisitions. Companies can also acquire government approvals and actively seek strategic collaborations. Manufacturing companies can leverage acquisitions and mergers to improve their technological abilities while staying competitive in the industry.

Key Developments:

• • In 2024 KAUST has teamed up with a health tech company in Saudi amplifAI Health to create an innovative solution for diabetes detection.
  • In 2023 the SFDA has granted Nemaura Medical approval for the sugarBEAT sensor which is a non invasive device designed to monitor glucose levels.
  • In 2023 Insulet Corporation purchased the pump patents from Bigfoot Biomedical which is a firm known for its innovations in insulin delivery solutions.
  • In 2022, Roche unveiled a new immediate blood glucose testing equipment for hospital use. It features a companion device that resembles a smartphone which supports its own app ecosystem.
  • In September 2021, Ministry of Investment in collaboration with Ministry of National Guard Health Affairs announced that it has signed a memoranda of understanding with Pfizer and AstraZeneca to establish clinical research centers in the Saudi Arabia.
  • In June 2021, the Saudi Food and Drug Authority (SFDA) updated about the “Transparency and Payment Disclosure Guidance for Medical and Food Companies”. Main purpose of this update to boost transparency in the health sector by establishing limits on spending by food and drug enterprises on training and education of physicians and medical institutes.

Segments covered in the Report:

The Saudi Arabia Diabetes Care Devices Market has been segmented on the basis of type outlook and end-user. Based on the type outlook, the market is segmented into blood glucose monitoring devices and insulin delivery devices. The blood glucose monitoring devices segment is further segmented into self-monitoring devices (blood glucose meters, testing strips, lancets) and continuous glucose monitoring devices (sensors, transmitters, receiver). The insulin delivery devices segment is further segmented into insulin pumps, insulin pens, and insulin syringes. Based on the end-user, the market is segmented into hospitals, homecare setting and others.

Market Segmentation

Saudi Arabia Diabetes Care Devices Market by Type Outlook

• • Blood Glucose Monitoring Devices
    • Self-monitoring Devices
      • Blood Glucose Meters
      • Testing Strips
      • Lancets
    • Continuous Glucose Monitoring Devices
      • Sensors
      • Transmitters
      • Receiver
  • Insulin Delivery Devices
    • Insulin Pumps
    • Insulin Pens
    • Insulin Syringes

Saudi Arabia Diabetes Care Devices Market by End-User

• • Hospitals
  • Homecare Setting
  • Others

Saudi Arabia Diabetes Care Devices Market Leading players (Option 1: Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • Abbott
  • Medtronic
  • Bayer AG
  • Lifescan